In today’s episode, we look at the emerging Omicron situation and new vaccines that have received the emergency use approval in India, including the oral-drug Molnupiravir. Will these vaccines help combat the sudden surge in COVID cases in the country? Will Molnupiravir be affordable and accessible to all?
Omicron: New vaccines get emergency use approval
Immunologist Dr. Satyajit Rath and NewsClick’s Prabir Purkayastha discuss the emerging Omicron situation and new vaccines that have received the emergency use approval in India, including the oral-drug Molnupiravir
